COVID-19 Booster Vaccines Administration in Different Countries
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that resulted in the COVID-19 global pandemic had consequently led to the development of different types of COVID-19 vaccines, including the messenger RNA (mRNA) vaccines, inactivated virus vaccines, a protein subunit vaccine, and vira...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
HH Publisher
2021-12-01
|
| Series: | Progress in Microbes and Molecular Biology |
| Online Access: | https://journals.hh-publisher.com/index.php/pmmb/article/view/517 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832541436790177792 |
|---|---|
| author | Angel Yun-Kuan Thye Loh Teng-Hern Tan Jodi Woan Fei Law Vengadesh Letchumanan |
| author_facet | Angel Yun-Kuan Thye Loh Teng-Hern Tan Jodi Woan Fei Law Vengadesh Letchumanan |
| author_sort | Angel Yun-Kuan Thye |
| collection | DOAJ |
| description | The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that resulted in the COVID-19 global pandemic had consequently led to the development of different types of COVID-19 vaccines, including the messenger RNA (mRNA) vaccines, inactivated virus vaccines, a protein subunit vaccine, and viral vector recombinant vaccines. Countries worldwide started their national vaccination program as soon as the COVID-19 vaccines got approved by the World Health Organization (WHO) under the emergency use listing. This includes COVID-19 vaccines by Pfizer-BioNTech, Moderna, AstraZeneca, Janssen, Sinovac, and Sinopharm. Findings suggested that protection against COVID-19 provided by these vaccines may be waning or that the protection reduces against variants of concern (VOC) or even inadequate protection of the primary vaccination for some risk groups. This led to the development of the COVID-19 booster vaccine that aims to improve and prolong the protection against COVID-19. This review aims to discuss the various COVID-19 booster vaccines that are being authorized and administered, the eligibility criteria for the different booster vaccines, and the extent of protection these booster vaccines provide in the United States (US), Israel, United Kingdom (UK), Singapore and Chile.
|
| format | Article |
| id | doaj-art-c45e6fca52664074ac280954fd411b60 |
| institution | Kabale University |
| issn | 2637-1049 |
| language | English |
| publishDate | 2021-12-01 |
| publisher | HH Publisher |
| record_format | Article |
| series | Progress in Microbes and Molecular Biology |
| spelling | doaj-art-c45e6fca52664074ac280954fd411b602025-02-04T08:40:10ZengHH PublisherProgress in Microbes and Molecular Biology2637-10492021-12-014110.36877/pmmb.a0000256COVID-19 Booster Vaccines Administration in Different CountriesAngel Yun-Kuan ThyeLoh Teng-Hern TanJodi Woan Fei LawVengadesh LetchumananThe severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that resulted in the COVID-19 global pandemic had consequently led to the development of different types of COVID-19 vaccines, including the messenger RNA (mRNA) vaccines, inactivated virus vaccines, a protein subunit vaccine, and viral vector recombinant vaccines. Countries worldwide started their national vaccination program as soon as the COVID-19 vaccines got approved by the World Health Organization (WHO) under the emergency use listing. This includes COVID-19 vaccines by Pfizer-BioNTech, Moderna, AstraZeneca, Janssen, Sinovac, and Sinopharm. Findings suggested that protection against COVID-19 provided by these vaccines may be waning or that the protection reduces against variants of concern (VOC) or even inadequate protection of the primary vaccination for some risk groups. This led to the development of the COVID-19 booster vaccine that aims to improve and prolong the protection against COVID-19. This review aims to discuss the various COVID-19 booster vaccines that are being authorized and administered, the eligibility criteria for the different booster vaccines, and the extent of protection these booster vaccines provide in the United States (US), Israel, United Kingdom (UK), Singapore and Chile. https://journals.hh-publisher.com/index.php/pmmb/article/view/517 |
| spellingShingle | Angel Yun-Kuan Thye Loh Teng-Hern Tan Jodi Woan Fei Law Vengadesh Letchumanan COVID-19 Booster Vaccines Administration in Different Countries Progress in Microbes and Molecular Biology |
| title | COVID-19 Booster Vaccines Administration in Different Countries |
| title_full | COVID-19 Booster Vaccines Administration in Different Countries |
| title_fullStr | COVID-19 Booster Vaccines Administration in Different Countries |
| title_full_unstemmed | COVID-19 Booster Vaccines Administration in Different Countries |
| title_short | COVID-19 Booster Vaccines Administration in Different Countries |
| title_sort | covid 19 booster vaccines administration in different countries |
| url | https://journals.hh-publisher.com/index.php/pmmb/article/view/517 |
| work_keys_str_mv | AT angelyunkuanthye covid19boostervaccinesadministrationindifferentcountries AT lohtengherntan covid19boostervaccinesadministrationindifferentcountries AT jodiwoanfeilaw covid19boostervaccinesadministrationindifferentcountries AT vengadeshletchumanan covid19boostervaccinesadministrationindifferentcountries |